Consumption of water containing a high concentration of molecular hydrogen reduces oxidative stress and disease activity in patients with rheumatoid arthritis: an open-label pilot study.
Toru Ishibashi, Bunpei Sato, Mariko Rikitake, Tomoki Seo, Ryosuke Kurokawa, Yuichi Hara, Yuji Naritomi, Hiroshi Hara, Tetsuhiko Nagao · Medical gas research · 2012
Research-use notice
Independent study record
Each H2HUBB study page organizes source-linked research details for educational use. Interpretation should remain proportional to the study design, population, controls, and limitations.
H2HUBB TAKEAWAY
The results suggest that the hydroxyl radical scavenger H₂ effectively reduces oxidative stress in patients with this condition. These findings add human evidence supporting molecular hydrogen's therapeutic potential for rheumatoid arthritis.
What the Findings Mean
H2HUBB reviewed how molecular hydrogen affected the outcomes measured in 20 patients with rheumatoid arthritis (RA). The results suggest that the hydroxyl radical scavenger H₂ effectively reduces oxidative stress in patients with this condition.
What the Researchers Studied
The researchers studied 20 patients with rheumatoid arthritis (RA). The study used a human clinical study.
What Effects Did Molecular Hydrogen Have?
Reported treatment duration: 4 weeks. The results suggest that the hydroxyl radical scavenger H₂ effectively reduces oxidative stress in patients with this condition.
Why These Findings Matter
These findings add human evidence supporting molecular hydrogen's therapeutic potential for rheumatoid arthritis and contribute to the growing body of molecular-hydrogen research.
How Strong Is This Evidence?
This is human clinical evidence from a human clinical study. H2HUBB interprets the findings in the context of the study design, sample, comparator, and measured outcomes rather than using one publication as a verdict on hydrogen therapy.
Technical Study Details
H2HUBB classifies this publication as human clinical study with human clinical evidence. The research population or model was 20 patients with rheumatoid arthritis (RA). The reported sample size was 20. The study used a human clinical study. The reported treatment duration was 4 weeks.
Limitations and Safety
No separate limitations or safety findings were identified in the source text available to H2HUBB.
Original Study and H2HUBB Research Context
H2HUBB presents this source-grounded research record as one contribution to the broader molecular-hydrogen evidence base.